TherapeuticsMD Inc (USD)
TXMD
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.43 | 1.54
52-Wk Range- | -
Last Close1.50
Mkt Cap (m)449.65
Dividend yield-
ISINUS88338N1072
Volume1,802.00
Exchange VenueNAS

Company Profile

TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales6.95
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 27/11/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.therapeuticsmd.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)20.1419.3616.7816.1049.65-
Operating Income (m)-85.19-90.25-77.63-130.22-151.21-
Net Income (m)-85.08-89.88-76.93-132.62-176.14-
Basic EPS-0.49-0.46-0.37-0.59-0.72-
Avg. Diluted Shares Outstanding (m)173.17196.09205.52225.03246.35-
Balance Sheet
USD201520162017201820192020
Current Assets (m)70.68139.41139.55186.78208.42-
Non Current Assets (m)3.053.063.6825.2057.57-
Total Assets (m)73.73142.47143.23211.98265.99-
Current Liabilities (m)10.6714.9813.3241.0853.00-
Total Liabilities (m)------
Total Equity (m)63.06127.49129.9197.529.20-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-79.04-69.14-76.16-106.81-165.70-
Capital Expenditure (m)-0.58-1.24-0.83-21.32-23.89-
Figures are quoted in USD unless stated otherwise
-
No change
$
1.50
Last Price